Skip to main content
Logo
European Innovation Council

ATXA Therapeutics Ltd

Pharmaceutical company focused on the small molecule drug NTP42 for the treatment of pulmonary arterial hypertension (PAH).

  • private sector
ATXA Therapeutics Ltd logo

Overview

Description

Pharmaceutical company focused on the small molecule drug NTP42 for the treatment of pulmonary arterial hypertension (PAH).

Website
Country
  • Ireland
Sector
  • Health Biotechnology

Engage with ATXA Therapeutics Ltd*

*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.